سوق علاج اضطرابات النوم العالمي – اتجاهات الصناعة والتوقعات حتى عام 2029

Request for TOC طلب جدول المحتويات Speak to Analyst تحدث إلى المحلل Buy Now اشتري الآن Inquire Before Buying استفسر قبل Free Sample Report تقرير عينة مجاني

سوق علاج اضطرابات النوم العالمي – اتجاهات الصناعة والتوقعات حتى عام 2029

  • Healthcare
  • Upcoming Report
  • Jul 2022
  • Global
  • 350 الصفحات
  • عدد الجداول: 220
  • عدد الأرقام: 60

Global Sleep Disorder Treatment Market

حجم السوق بالمليار دولار أمريكي

CAGR :  % Diagram

Diagram فترة التنبؤ
2022 –2029
Diagram حجم السوق (السنة الأساسية)
USD 8,551.42 Million
Diagram حجم السوق (سنة التنبؤ)
USD 16,914.58 Million
Diagram CAGR
%
Diagram اللاعبين الرئيسيين في الأسواق
  • Jazz Pharmaceuticals
  • Pfizer
  • Viatris
  • Arbor Pharmaceuticals
  • Aurobindo Pharma

>السوق العالمية لعلاج اضطرابات النوم، حسب النوع ( الأرق ، انقطاع النفس أثناء النوم، متلازمة تململ الساقين، الخدار وغيرها)، العلاج (العلاج الدوائي، العلاج الميكانيكي، أجهزة تقدم الفك السفلي، محفز العصب تحت اللسان، الجراحة وغيرها) طريق الإدارة (عن طريق الفم، عن طريق الحقن وغيرها)، نوع الدواء (العلامة التجارية والأدوية الجنيسة)، نوع السكان (الأطفال والبالغين)، المستخدم النهائي (المستشفيات، العيادات المتخصصة، الرعاية الصحية المنزلية، مركز الجراحة الخارجية وغيرها)، قناة التوزيع (العطاء المباشر، صيدلية المستشفى، صيدلية التجزئة، الصيدلة عبر الإنترنت وغيرها) - اتجاهات الصناعة والتوقعات حتى عام 2029

سوق علاج اضطرابات النوم

تحليل السوق والحجم

اضطراب النوم، المعروف أيضًا بالأرق، هو حالة طبية يعاني فيها المريض من صعوبة في الحفاظ على النوم أو البدء فيه. تؤدي هذه الحالة إلى تعطيل الوظائف العقلية والجسدية والاجتماعية والعاطفية. علاوة على ذلك، فإن إدخال أدوات اختبار النوم المنزلية، بالإضافة إلى استخدام أجهزة المراقبة القابلة للارتداء وعلاج الضغط الهوائي الإيجابي المستمر (CPAP)، يوسع فرص السوق.

تحلل شركة Data Bridge Market Research أن سوق علاج اضطرابات النوم الذي بلغ 8551.42 مليون دولار أمريكي في عام 2021، سيرتفع إلى 16914.58 مليون دولار أمريكي بحلول عام 2029، ومن المتوقع أن يخضع لمعدل نمو سنوي مركب بنسبة 8.90٪ خلال الفترة المتوقعة من 2022 إلى 2029. بالإضافة إلى رؤى السوق مثل القيمة السوقية ومعدل النمو وشرائح السوق والتغطية الجغرافية واللاعبين في السوق وسيناريو السوق، يتضمن تقرير السوق الذي أعده فريق Data Bridge Market Research أيضًا تحليلًا متعمقًا من الخبراء وعلم الأوبئة للمرضى وتحليل خطوط الأنابيب وتحليل الأسعار والإطار التنظيمي.

نطاق التقرير وتقسيم السوق

تقرير القياس

تفاصيل

فترة التنبؤ

2022 إلى 2029

سنة الأساس

2021

سنوات تاريخية

2020 (قابلة للتخصيص حتى 2014 - 2019)

وحدات كمية

الإيرادات بالملايين من الدولارات الأمريكية، الأحجام بالوحدات، التسعير بالدولار الأمريكي

القطاعات المغطاة

النوع (الأرق، انقطاع النفس أثناء النوم، متلازمة تململ الساقين، الخدار وغيرها)، العلاج (العلاج الدوائي، العلاج الميكانيكي، أجهزة تقدم الفك السفلي، محفز العصب تحت اللسان، الجراحة وغيرها)، طريق الإعطاء (عن طريق الفم، عن طريق الحقن وغيرها)، نوع الدواء (ماركة تجارية وعامة)، نوع السكان (الأطفال والبالغين)، المستخدم النهائي (المستشفيات، العيادات المتخصصة، الرعاية الصحية المنزلية ، مركز الجراحة الخارجية وغيرها)، قناة التوزيع (العطاء المباشر، صيدلية المستشفى، صيدلية التجزئة، الصيدلة عبر الإنترنت وغيرها)

الدول المغطاة

الولايات المتحدة وكندا والمكسيك في أمريكا الشمالية وألمانيا وفرنسا والمملكة المتحدة وهولندا وسويسرا وبلجيكا وروسيا وإيطاليا وإسبانيا وتركيا وبقية دول أوروبا في أوروبا والصين واليابان والهند وكوريا الجنوبية وسنغافورة وماليزيا وأستراليا وتايلاند وإندونيسيا والفلبين وبقية دول آسيا والمحيط الهادئ (APAC) في منطقة آسيا والمحيط الهادئ (APAC) والمملكة العربية السعودية والإمارات العربية المتحدة وجنوب أفريقيا ومصر وإسرائيل وبقية دول الشرق الأوسط وأفريقيا (MEA) كجزء من الشرق الأوسط وأفريقيا (MEA) والبرازيل والأرجنتين وبقية دول أمريكا الجنوبية كجزء من أمريكا الجنوبية

الجهات الفاعلة في السوق المشمولة

Jazz Pharmaceuticals, Inc. (أيرلندا)، Pfizer Inc. (الولايات المتحدة)، Viatris Inc. (الولايات المتحدة)، Arbor Pharmaceuticals Inc. (الولايات المتحدة)، Aurobindo Pharma USA (الولايات المتحدة)، Sanofi (الولايات المتحدة)، Hikma Pharmaceuticals PLC (المملكة المتحدة)، Amneal Pharmaceuticals LLC (الولايات المتحدة)، Lupin Pharmaceuticals, Inc. (الهند)، Taj Pharmaceuticals Limited (الهند)، Eli Lilly and Company (الولايات المتحدة)، Mallinckrodt (المملكة المتحدة)، Alembic Pharmaceuticals Limited (الهند)، Apotex Inc. (كندا)، Dr. Reddy's Laboratories Ltd. (الهند)، Teva Pharmaceuticals Industries Ltd. (الهند)، Taro Pharmaceutical Industries Ltd. (الولايات المتحدة)، DeVilbiss Healthcare LLC (الولايات المتحدة)، ResMed (الولايات المتحدة)

فرص السوق

  •  ارتفاع مستويات التوتر وتغير الديناميكيات
  • وجود مرشحين محتملين لخطوط الأنابيب السريرية

تعريف السوق

عندما يعاني المريض من حالة نوم، مثل انقطاع النفس أثناء النوم، أو الخدار، أو الأرق، فقد يواجه صعوبة في النوم أو الاستمرار في النوم. وتؤدي هذه الحالة إلى عمليات عقلية وجسدية واجتماعية وعاطفية غير طبيعية. وتُستخدم العديد من الأساليب العلاجية لعلاج مشاكل النوم اعتمادًا على أعراض المريض.

ديناميكيات سوق علاج اضطرابات النوم

السائقين

  • ارتفاع اضطرابات النوم

إن الطلب على بدائل علاج مشاكل النوم سوف يرتفع مع انتشار اضطرابات النوم بشكل أكبر. وبالتالي، فمن المتوقع أن يؤدي الضغط النفسي المتزايد الناجم عن نمط الحياة المزدحم والسلوكيات السيئة إلى توسع سوق علاج اضطرابات النوم. وقد يخشى المرضى من الاستهلاك بسبب خطورة الآثار السلبية، مما يؤدي إلى انخفاض الطلب والمبيعات. إن التطور التكنولوجي المتزايد يخلق فرصة لزيادة حاجة السوق إلى علاجات مشاكل النوم.

  • ارتفاع الإنفاق على الرعاية الصحية

ومن المتوقع أن تشمل العوامل التي من شأنها أن تدفع نمو هذا القطاع خلال الفترة المتوقعة ارتفاع الإنفاق على الرعاية الصحية والتشخيص المبكر للحالة بسبب زيادة الوعي بالبدائل المتاحة للعلاج .

  • زيادة انتشار اضطرابات النوم

إن الزيادة العالمية في انتشار اضطرابات النوم مثل انقطاع النفس أثناء النوم والأرق والنوم القهري هي المحرك لسوق علاج اضطرابات النوم.

فرص

وقد تلعب هذه العناصر دورًا في ارتفاع الطلب على الأدوية في هذه الدول. ومن المتوقع أن يزداد الطلب خلال الفترة المتوقعة نتيجة للسياسات المحسّنة باستمرار لسداد تكاليف الرعاية الصحية. بالإضافة إلى ذلك، أدى ارتفاع مستويات المعيشة إلى تعزيز الطلب المحلي. ومن المتوقع أن تعمل هذه المتغيرات على تسريع توسع السوق الإقليمية في السنوات القادمة.

القيود/التحديات

تشكل التكلفة المرتفعة لعلاج اضطرابات النوم عائقًا أمام توسع السوق.

يقدم تقرير سوق علاج اضطرابات النوم هذا تفاصيل عن التطورات الحديثة الجديدة واللوائح التجارية وتحليل الاستيراد والتصدير وتحليل الإنتاج وتحسين سلسلة القيمة وحصة السوق وتأثير اللاعبين المحليين والمحليين في السوق وتحليل الفرص من حيث جيوب الإيرادات الناشئة والتغييرات في لوائح السوق وتحليل نمو السوق الاستراتيجي وحجم السوق ونمو سوق الفئات ومنافذ التطبيق والهيمنة وموافقات المنتجات وإطلاق المنتجات والتوسعات الجغرافية والابتكارات التكنولوجية في السوق. للحصول على مزيد من المعلومات حول سوق علاج اضطرابات النوم، اتصل بـ Data Bridge Market Research للحصول على موجز محلل، وسيساعدك فريقنا في اتخاذ قرار سوقي مستنير لتحقيق نمو السوق.

التطورات الأخيرة

  • أعلنت شركة Jazz Pharmaceuticals plc في يوليو 2020 أن إدارة الغذاء والدواء الأمريكية قد وافقت على دوائها Xyway لعلاج الخدار والنعاس المفرط أثناء النهار لدى مرضى الخدار الذين تزيد أعمارهم عن 15 عامًا. وقد أدى علاج اضطراب النوم الجديد للشركة، والذي تمت الموافقة عليه من قبل إدارة الغذاء والدواء الأمريكية، إلى زيادة الطلب في السوق ومبيعات الدواء، مما سيؤدي إلى زيادة الإيرادات في المستقبل.
  • تم تقديم قرص أرمودافينيل، وهو شكل عام من دواء نوفيجيل، من قبل شركة Mylan NV في يونيو 2016 لعلاج الأفراد الذين يعانون من النعاس المفرط بسبب انقطاع النفس الانسدادي أثناء النوم، أو النوم القهري، أو اضطراب العمل بنظام الورديات.

نطاق سوق علاج اضطرابات النوم العالمية

يتم تقسيم سوق علاج اضطرابات النوم على أساس النوع والعلاج وطريقة الإدارة ونوع الدواء ونوع السكان والمستخدم النهائي وقناة التوزيع. سيساعدك النمو بين هذه القطاعات على تحليل قطاعات النمو الضئيلة في الصناعات وتزويد المستخدمين بنظرة عامة قيمة على السوق ورؤى السوق لمساعدتهم على اتخاذ قرارات استراتيجية لتحديد تطبيقات السوق الأساسية.

يكتب

  • أرق
  • انقطاع التنفس أثناء النوم
  • متلازمة تململ الساقين
  • النوم القهري
  • آحرون

علاج

  • العلاج الدوائي
  • العلاج الميكانيكي
  • أجهزة تقدم الفك السفلي
  • محفز العصب تحت اللساني
  • جراحة
  • آحرون

طريق الإدارة

  • شفوي
  • الحقن الوريدي
  • آحرون

 نوع المخدرات

  • العلامة التجارية
  • الأنواع العامة

نوع السكان

  • أطفال
  • البالغون

 المستخدم النهائي

قناة التوزيع

  • العطاء المباشر
  • صيدلية المستشفى
  • صيدلية التجزئة
  • صيدلية على الإنترنت
  • آحرون

تحليل/رؤى إقليمية لسوق علاج اضطرابات النوم

يتم تحليل سوق علاج اضطرابات النوم وتوفير رؤى حجم السوق والاتجاهات حسب البلد والنوع والعلاج وطريقة الإدارة ونوع الدواء ونوع السكان والمستخدم النهائي وقناة التوزيع كما هو مذكور أعلاه.

الدول التي يغطيها تقرير سوق علاج اضطرابات النوم هي الولايات المتحدة وكندا والمكسيك في أمريكا الشمالية وألمانيا وفرنسا والمملكة المتحدة وهولندا وسويسرا وبلجيكا وروسيا وإيطاليا وإسبانيا وتركيا وبقية أوروبا في أوروبا والصين واليابان والهند وكوريا الجنوبية وسنغافورة وماليزيا وأستراليا وتايلاند وإندونيسيا والفلبين وبقية دول آسيا والمحيط الهادئ (APAC) في منطقة آسيا والمحيط الهادئ (APAC) والمملكة العربية السعودية والإمارات العربية المتحدة وجنوب إفريقيا ومصر وإسرائيل وبقية دول الشرق الأوسط وأفريقيا (MEA) كجزء من الشرق الأوسط وأفريقيا (MEA) والبرازيل والأرجنتين وبقية دول أمريكا الجنوبية كجزء من أمريكا الجنوبية.

تسيطر أمريكا الشمالية على السوق بسبب معدل التشخيص المتزايد والوعي بالمرض، كما أن الناس يعيشون جدول حياة مزدحم.

ومن المتوقع أن تشهد منطقة آسيا والمحيط الهادئ نمواً بفضل التقدم في التكنولوجيات الجديدة.

يقدم قسم الدولة في التقرير أيضًا عوامل التأثير الفردية على السوق والتغييرات في التنظيم في السوق محليًا والتي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. نقاط البيانات مثل تحليل سلسلة القيمة المصب والمصب، والاتجاهات الفنية وتحليل قوى بورتر الخمس، ودراسات الحالة هي بعض المؤشرات المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. أيضًا، يتم النظر في وجود وتوافر العلامات التجارية العالمية والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من العلامات التجارية المحلية والمحلية، وتأثير التعريفات الجمركية المحلية وطرق التجارة أثناء تقديم تحليل توقعات لبيانات الدولة.

تحليل المنافسة وحصة سوق علاج اضطرابات النوم

يوفر المشهد التنافسي لسوق علاج اضطرابات النوم تفاصيل حسب المنافس. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المتولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، والحضور العالمي، ومواقع الإنتاج والمرافق، والقدرات الإنتاجية، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وعرض المنتج ونطاقه، وهيمنة التطبيق. ترتبط نقاط البيانات المذكورة أعلاه فقط بتركيز الشركات فيما يتعلق بسوق علاج اضطرابات النوم.

بعض اللاعبين الرئيسيين العاملين في سوق علاج اضطرابات النوم هم:

  • شركة جاز للأدوية (أيرلندا)
  • شركة فايزر (الولايات المتحدة)
  • شركة فياتريس (الولايات المتحدة)
  • شركة أربور للأدوية (الولايات المتحدة)
  • أوروبيندو فارما الولايات المتحدة الأمريكية (الولايات المتحدة)
  • سانوفي (الولايات المتحدة)
  • شركة هيكما للادوية المحدودة (المملكة المتحدة)
  • شركة أمينيل للأدوية ذ.م.م (الولايات المتحدة)
  • شركة لوبين للأدوية (الهند)
  • شركة تاج للأدوية المحدودة (الهند)
  • شركة إيلي ليلي (الولايات المتحدة)
  • مالينكرودت (المملكة المتحدة)
  • شركة أليمبيك للأدوية المحدودة (الهند)
  • شركة أبوتكس (كندا)
  • مختبرات الدكتور ريدي المحدودة (الهند)
  • شركة تيفا للصناعات الدوائية المحدودة (الهند)
  • شركة تارو للصناعات الدوائية المحدودة (الولايات المتحدة)
  • شركة ديفيلبيس للرعاية الصحية ذ.م.م (الولايات المتحدة)
  • ريس ميد (الولايات المتحدة)


SKU-

احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم

  • لوحة معلومات تحليل البيانات التفاعلية
  • لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
  • إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
  • تحليل المنافسين باستخدام لوحة معلومات تفاعلية
  • آخر الأخبار والتحديثات وتحليل الاتجاهات
  • استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL SLEEP DISORDER TREATMENT MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

5 GLOBAL SLEEP DISORDER TREATMENT MARKET: REGULATIONS

6 GLOBAL SLEEP DISORDER TREATMENT MARKET: PIPELINE ANALYSIS

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 RISING PREVALENCE OF SLEEPING DISORDERS

7.1.2 RISE IN THE GERIATRIC POPULATION

7.1.3 INCREASE IN MENTAL STRESS DUE TO HECTIC LIFE & UNHEALTHY HABITS

7.1.4 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS

7.1.5 PRESENCE OF POTENTIAL CLINICAL PIPELINE CANDIDATES

7.2 RESTRAINTS

7.2.1 SIDE EFFECTS ASSOCIATED WITH THESE DRUGS

7.2.2 PATENT EXPIRATION OF MAJOR SLEEP DISORDER TREATMENT DRUGS

7.2.3 EMERGENCE OF GENERICS

7.3 OPPORTUNITIES

7.3.1 TECHNOLOGICAL ADVANCEMENTS IN THE SLEEP AIDS

7.3.2 INCREASING USAGE OF SOCIAL MEDIA AND GROWING ADDICTION OF GADGETS SUCH AS SMARTPHONES AND LAPTOPS

7.3.3 GROWING AWARENESS ABOUT TARGET DISEASE

7.4 CHALLENGES

7.4.1 HIGH COST OF DIAGNOSIS & TREATMENT FOR SLEEPING DISORDER

7.4.2 STRINGENT REGULATORY LANDSCAPE

7.4.3 POTENTIAL ILL-EFFECTS DUE TO DRUG ABUSE

8 IMPACT OF COVID-19 ON GLOBAL SLEEP DISORDER TREATMENT MARKET

8.1 PRICE IMPACT

8.2 IMPACT ON DEMAND

8.3 IMPACT ON SUPPLY CHAIN

8.4 STRATEGIC INITIATIVES BY MARKET PLAYERS DURING COVID-19

8.5 CONCLUSION

9 GLOBAL SLEEP DISORDER TREATMENT MARKET, BY TYPE

9.1 OVERVIEW

9.2 INSOMNIA

9.2.1 INSOMNIA

9.2.2 CHILD INSOMNIA

9.2.3 OTHERS

9.3 SLEEP APNEA

9.3.1 OBSTRUCTIVE SLEEP APNEA

9.3.2 CENTRAL SLEEP APNEA

9.3.3 SNORING

9.3.4 INFANT SLEEP APNEA

9.3.5 OTHERS

9.4 RESTLESS LEGS SYNDROME (RLS)

9.5 NARCOLEPSY

9.5.1 TYPE 1

9.5.2 TYPE 2

10 GLOBAL SLEEP DISORDER TREATMENT MARKET, BY TREATMENT

10.1 OVERVIEW

10.2 PHARMACOLOGICAL THERAPY

10.2.1 CANNABIDIOL

10.2.2 ANTI-PARKINSONIAN DRUGS (DOPAMINE AGONISTS)

10.2.3 BENZODIAZEPINES

10.2.4 NON-BENZODIAZEPINE

10.2.5 MELATONIN RECEPTOR STIMULATOR

10.2.6 STIMULANTS

10.2.7 SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) OR SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS)

10.2.8 TRICYCLIC ANTIDEPRESSANTS

10.2.9 SODIUM OXYBATE (XYREM)

10.2.10 OTHERS

10.3 MECHANICAL THERAPY

10.3.1 CPAP (CONTINUOUS POSITIVE AIRWAY PRESSURE)

10.3.2 BI-LEVEL PAP

10.3.3 AUTO CPAP OR AUTO BI-LEVEL PAP

10.3.4 ADAPTIVE SERVO-VENTILATION (ASV)

10.4 MANDIBULAR ADVANCEMENT DEVICES

10.5 HYPOGLOSSAL NERVE STIMULATOR

10.6 SURGERY

10.6.1 SOMNOPLASTY

10.6.2 TONSILLECTOMY

10.6.3 NASAL SURGERY

10.6.4 OTHERS

10.7 OTHERS

11 GLOBAL SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

11.1 OVERVIEW

11.2 ORAL

11.2.1 TABLET

11.2.2 PILLS

11.2.3 OTHERS

11.3 PARENTERAL

11.4 OTHERS

12 GLOBAL SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE

12.1 OVERVIEW

12.2 GENERICS

12.3 BRANDED

12.3.1 XYREM

12.3.2 EFFEXOR XR

12.3.3 AMBIEN

12.3.4 PRISTIQ

12.3.5 ZENZEDI

12.3.6 VYVANSE

12.3.7 OTHERS

13 GLOBAL SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE

13.1 OVERVIEW

13.2 ADULT

13.3 CHILDREN

14 GLOBAL SLEEP DISORDER TREATMENT MARKET, BY END USER

14.1 OVERVIEW

14.2 HOSPITALS

14.3 SPECIALTY CLINICS

14.4 HOME HEALTHCARE

14.5 AMBULATORY SURGICAL CENTER

14.6 OTHERS

15 GLOBAL SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL

15.1 OVERVIEW

15.2 DIRECT TENDER

15.3 HOSPITAL PHARMACY

15.4 RETAIL PHARMACY

15.5 ONLINE PHARMACY

15.6 OTHERS

16 GLOBAL SLEEP DISORDER TREATMENT MARKET, BY GEOGRAPHY

16.1 OVERVIEW

16.2 NORTH AMERICA

16.2.1 U.S.

16.2.2 CANADA

16.2.3 MEXICO

16.3 EUROPE

16.3.1 GERMANY

16.3.2 FRANCE

16.3.3 U.K.

16.3.4 ITALY

16.3.5 SPAIN

16.3.6 RUSSIA

16.3.7 IRELAND

16.3.8 NORWAY

16.3.9 POLAND

16.3.10 TURKEY

16.3.11 HUNGARY

16.3.12 AUSTRIA

16.3.13 LITHUANIA

16.3.14 NETHERLANDS

16.3.15 SWITZERLAND

16.3.16 REST OF EUROPE

16.4 ASIA-PACIFIC

16.4.1 JAPAN

16.4.2 CHINA

16.4.3 SOUTH KOREA

16.4.4 INDIA

16.4.5 AUSTRALIA

16.4.6 SINGAPORE

16.4.7 THAILAND

16.4.8 MALAYSIA

16.4.9 INDONESIA

16.4.10 PHILIPPINES

16.4.11 VIETNAM

16.4.12 REST OF ASIA-PACIFIC

16.5 SOUTH AMERICA

16.5.1 BRAZIL

16.5.2 ARGENTINA

16.5.3 PERU

16.5.4 REST OF SOUTH AMERICA

16.6 MIDDLE EAST AND AFRICA

16.6.1 SOUTH AFRICA

16.6.2 SOUTH ARABIA

16.6.3 UAE

16.6.4 EGYPT

16.6.5 KUWAIT

16.6.6 ISRAEL

16.6.7 REST OF MIDDLE EAST AND AFRICA

17 GLOBAL SLEEP DISORDER TREATMENT MARKET: COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: GLOBAL

17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

17.3 COMPANY SHARE ANALYSIS: EUROPE

17.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

18 SWOT ANALYSIS

19 COMPANY PROFILE

19.1 JAZZ PHARMACEUTICALS, INC.

19.1.1 COMPANY SNAPSHOT

19.1.2 REVENUE ANALYSIS

19.1.3 COMPANY SHARE ANALYSIS

19.1.4 PRODUCT PORTFOLIO

19.1.5 RECENT DEVELOPMENTS

19.2 PFIZER INC.

19.2.1 COMPANY SNAPSHOT

19.2.2 REVENUE ANALYSIS

19.2.3 COMPANY SHARE ANALYSIS

19.2.4 PRODUCT PORTFOLIO

19.2.5 RECENT DEVELOPMENT

19.3 ELI LILLY AND COMPANY

19.3.1 COMPANY SNAPSHOT

19.3.2 REVENUE ANALYSIS

19.3.3 COMPANY SHARE ANALYSIS

19.3.4 PRODUCT PORTFOLIO

19.3.5 RECENT DEVELOPMENTS

19.4 VIATRIS INC.

19.4.1 COMPANY SNAPSHOT

19.4.2 REVENUE ANALYSIS

19.4.3 COMPANY SHARE ANALYSIS

19.4.4 PRODUCT PORTFOLIO

19.4.5 RECENT DEVELOPMENTS

19.5 RESMED

19.5.1 COMPANY SNAPSHOT

19.5.2 REVENUE ANALYSIS

19.5.3 PRODUCT PORTFOLIO

19.5.4 RECENT DEVELOPMENTS

19.6 MALLINCKRODT

19.6.1 COMPANY SNAPSHOT

19.6.2 REVENUE ANALYSIS

19.6.3 PRODUCT PORTFOLIO

19.6.4 RECENT DEVELOPMENT

19.7 KONINKLIJKE PHILIPS N.V.

19.7.1 COMPANY SNAPSHOT

19.7.2 REVENUE ANALYSIS

19.7.3 PRODUCT PORTFOLIO

19.7.4 RECENT DEVELOPMENTS

19.8 ALEMBIC PHARMACEUTICALS LIMITED

19.8.1 COMPANY SNAPSHOT

19.8.2 REVENUE ANALYSIS

19.8.3 PRODUCT PORTFOLIO

19.8.4 RECENT DEVELOPMENT

19.9 AMNEAL PHARMACEUTICALS LLC

19.9.1 COMPANY SNAPSHOT

19.9.2 REVENUE ANALYSIS

19.9.3 PRODUCT PORTFOLIO

19.9.4 RECENT DEVELOPMENTS

19.1 APOTEX INC.

19.10.1 COMPANY SNAPSHOT

19.10.2 PRODUCT PORTFOLIO

19.10.3 RECENT DEVELOPMENT

19.11 ARBOR PHARMACEUTICALS

19.11.1 COMPANY SNAPSHOT

19.11.2 PRODUCT PORTFOLIO

19.11.3 RECENT DEVELOPMENTS

19.12 AUROBINDO PHARMA USA (A SUBSIDIARY OF AUROBINDO PHARMA)

19.12.1 COMPANY SNAPSHOT

19.12.2 REVENUE ANALYSIS

19.12.3 PRODUCT PORTFOLIO

19.12.4 RECENT DEVELOPMENTS

19.13 BMC MEDICAL CO.

19.13.1 COMPANY SNAPSHOT

19.13.2 PRODUCT PORTFOLIO

19.13.3 RECENT DEVELOPMENT

19.14 DEVILBISS HEALTHCARE LLC

19.14.1 COMPANY SNAPSHOT

19.14.2 PRODUCT PORTFOLIO

19.14.3 RECENT DEVELOPMENT

19.15 DR. REDDY’S LABORATORIES LTD.

19.15.1 COMPANY SNAPSHOT

19.15.2 REVENUE ANALYSIS

19.15.3 PRODUCT PORTFOLIO

19.15.4 RECENT DEVELOPMENT

19.16 HIKMA PHARMACEUTICALS PLC

19.16.1 COMPANY SNAPSHOT

19.16.2 REVENUE ANALYSIS

19.16.3 PRODUCT PORTFOLIO

19.16.4 RECENT DEVELOPMENTS

19.17 LUPIN PHARMACEUTICALS, INC. (A SUBSIDIARY OF LUPIN)

19.17.1 COMPANY SNAPSHOT

19.17.2 REVENUE ANALYSIS

19.17.3 PRODUCT PORTFOLIO

19.17.4 RECENT DEVELOPMENTS

19.18 OVENTUS

19.18.1 COMPANY SNAPSHOT

19.18.2 REVENUE ANALYSIS

19.18.3 PRODUCT PORTFOLIO

19.18.4 RECENT DEVELOPMENTS

19.19 SANOFI-AVENTIS U.S. LLC (A SUBSIDIARY OF SANOFI)

19.19.1 COMPANY SNAPSHOT

19.19.2 REVENUE ANALYSIS

19.19.3 PRODUCT PORTFOLIO

19.19.4 RECENT DEVELOPMENTS

19.2 SOMNOMED

19.20.1 COMPANY SNAPSHOT

19.20.2 REVENUE ANALYSIS

19.20.3 PRODUCT PORTFOLIO

19.20.4 RECENT DEVELOPMENTS

19.21 TAJ PHARMACEUTICALS LIMITED

19.21.1 COMPANY SNAPSHOT

19.21.2 PRODUCT PORTFOLIO

19.21.3 RECENT DEVELOPMENT

19.22 TARO PHARMACEUTICAL INDUSTRIES LTD.

19.22.1 COMPANY SNAPSHOT

19.22.2 REVENUE ANALYSIS

19.22.3 PRODUCT PORTFOLIO

19.22.4 RECENT DEVELOPMENT

19.23 TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD.)

19.23.1 COMPANY SNAPSHOT

19.23.2 REVENUE ANALYSIS

19.23.3 PRODUCT PORTFOLIO

19.23.4 RECENT DEVELOPMENTS

20 QUESTIONNAIRE

21 RELATED REPORTS

List of Table

LIST OF TABLES 

TABLE 1 GLOBAL SLEEP DISORDER TREATMENT MARKET: PIPELINE ANALYSIS

TABLE 2 GENERIC DRUGS FOR SLEEP DISORDER TREATMENT

TABLE 3 GLOBAL SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2018-2028 (USD MILLION)

TABLE 4 GLOBAL SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2018-2028 (USD MILLION)

TABLE 5 GLOBAL INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 6 GLOBAL SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 7 GLOBAL SLEEP SPNEA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 8 GLOBAL RESTLESS LEGS SYNDROME (RLS) IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 9 GLOBAL NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 10 GLOBAL NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 11 GLOBAL SLEEP DISORDER TREATMENT MARKET, BY TREATMENT, 2018-2028 (USD MILLION)

TABLE 12 GLOBAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 13 GLOBAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 14 GLOBAL MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 15 GLOBAL MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 16 GLOBAL MANDIBULAR ADVANCEMENT DEVICES IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 17 GLOBAL HYPOGLOSSAL NERVE STIMULATOR IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 18 GLOBAL SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 19 GLOBAL SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 20 GLOBAL OTHERS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 21 GLOBAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 22 GLOBAL ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 23 GLOBAL ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 24 GLOBAL PARENTERAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 25 GLOBAL OTHERS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 26 GLOBAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 27 GLOBAL GENERICS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 28 GLOBAL BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 29 GLOBAL BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 30 GLOBAL SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE, 2018-2028 (USD MILLION)

TABLE 31 GLOBAL ADULT IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 32 GLOBAL CHILDREN IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 33 GLOBAL SLEEP DISORDER TREATMENT MARKET, BY END USER, 2018-2028 (USD MILLION)

TABLE 34 GLOBAL HOSPITALS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 35 GLOBAL SPECIALTY CLINICS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 36 GLOBAL HOME HEALTHCARE IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 37 GLOBAL AMBULATORY SURGICAL CENTER IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 38 GLOBAL OTHERS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 39 GLOBAL SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2028 (USD MILLION)

TABLE 40 GLOBAL DIRECT TENDER IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 41 GLOBAL HOSPITAL PHARMACY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 42 GLOBAL RETAIL PHARMACY IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 43 GLOBAL ONLINE PHARMACY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 44 GLOBAL HOSPITALS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION

TABLE 45 GLOBAL SLEEP DISORDER TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 46 NORTH AMERICA SLEEP DISORDER TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 47 NORTH AMERICA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 NORTH AMERICA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 49 NORTH AMERICA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 50 NORTH AMERICA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 51 NORTH AMERICA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 52 NORTH AMERICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 53 NORTH AMERICA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 54 NORTH AMERICA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 55 NORTH AMERICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 56 NORTH AMERICA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 57 NORTH AMERICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 58 NORTH AMERICA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 59 NORTH AMERICA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 60 NORTH AMERICA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 61 NORTH AMERICA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 62 U.S. SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 63 U.S. INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 64 U.S. SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 65 U.S. NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 66 U.S. SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 67 U.S. PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 68 U.S. MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 69 U.S. SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 70 U.S. PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 71 U.S. ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 72 U.S. PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 73 U.S. BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 74 U.S. SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 75 U.S. SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 76 U.S. SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 77 CANADA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 78 CANADA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 79 CANADA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 80 CANADA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 81 CANADA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 82 CANADA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 83 CANADA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 84 CANADA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 85 CANADA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 86 CANADA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 87 CANADA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 88 CANADA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 89 CANADA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 90 CANADA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 91 CANADA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 92 MEXICO SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 93 MEXICO INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 94 MEXICO SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 95 MEXICO NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 96 MEXICO SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 97 MEXICO PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 98 MEXICO MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 99 MEXICO SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 100 MEXICO PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 101 MEXICO ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 102 MEXICO PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 103 MEXICO BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 104 MEXICO SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 105 MEXICO SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 106 MEXICO SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 107 EUROPE SLEEP DISORDER TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 108 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 109 EUROPE INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 110 EUROPE SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 111 EUROPE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 112 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 113 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 114 EUROPE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 115 EUROPE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 116 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 117 EUROPE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 118 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 119 EUROPE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 120 EUROPE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 121 EUROPE SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 122 EUROPE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 123 GERMANY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 124 GERMANY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 125 GERMANY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 126 GERMANY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 127 GERMANY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 128 GERMANY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 129 GERMANY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 130 GERMANY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 131 GERMANY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 132 GERMANY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 133 GERMANY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 134 GERMANY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 135 GERMANY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 136 GERMANY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 137 GERMANY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 138 FRANCE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 139 FRANCE INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 140 FRANCE SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 141 FRANCE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 142 FRANCE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 143 FRANCE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 144 FRANCE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 145 FRANCE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 146 FRANCE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 147 FRANCE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 148 FRANCE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 149 FRANCE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 150 FRANCE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 151 FRANCE SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 152 FRANCE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 153 U.K. SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 154 U.K. INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 155 U.K. SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 156 U.K. NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 157 U.K. SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 158 U.K. PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 159 U.K. MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 160 U.K. SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 161 U.K. PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 162 U.K. ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 163 U.K. PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 164 U.K. BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 165 U.K. SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 166 U.K. SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 167 U.K. SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 168 ITALY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 169 ITALY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 170 ITALY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 171 ITALY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 172 ITALY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 173 ITALY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 174 ITALY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 175 ITALY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 176 ITALY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 177 ITALY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 178 ITALY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 179 ITALY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 180 ITALY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 181 ITALY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 182 ITALY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 183 SPAIN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 184 SPAIN INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 185 SPAIN SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 186 SPAIN NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 187 SPAIN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 188 SPAIN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 189 SPAIN MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 190 SPAIN SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 191 SPAIN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 192 SPAIN ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 193 SPAIN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 194 SPAIN BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 195 SPAIN SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 196 SPAIN SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 197 SPAIN SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 198 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 199 RUSSIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 200 RUSSIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 201 RUSSIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 202 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 203 RUSSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 204 RUSSIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 205 RUSSIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 206 RUSSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 207 RUSSIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 208 RUSSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 209 RUSSIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 210 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 211 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 212 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 213 IRELAND SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 214 IRELAND INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 215 IRELAND SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 216 IRELAND NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 217 IRELAND SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 218 IRELAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 219 IRELAND MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 220 IRELAND SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 221 IRELAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 222 IRELAND ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 223 IRELAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 224 IRELAND BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 225 IRELAND SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 226 IRELAND SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 227 IRELAND SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 228 NORWAY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 229 NORWAY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 230 NORWAY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 231 NORWAY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 232 NORWAY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 233 NORWAY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 234 NORWAY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 235 NORWAY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 236 NORWAY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 237 NORWAY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 238 NORWAY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 239 NORWAY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 240 NORWAY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 241 NORWAY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 242 NORWAY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 243 POLAND SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 244 POLAND INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 245 POLAND SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 246 POLAND NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 247 POLAND SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 248 POLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 249 POLAND MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 250 POLAND SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 251 POLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 252 POLAND ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 253 POLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 254 POLAND BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 255 POLAND SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 256 POLAND SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 257 POLAND SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 258 TURKEY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 259 TURKEY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 260 TURKEY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 261 TURKEY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 262 TURKEY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 263 TURKEY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 264 TURKEY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 265 TURKEY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 266 TURKEY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 267 TURKEY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 268 TURKEY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 269 TURKEY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 270 TURKEY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 271 TURKEY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 272 TURKEY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 273 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 274 HUNGARY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 275 HUNGARY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 276 HUNGARY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 277 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 278 HUNGARY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 279 HUNGARY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 280 HUNGARY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 281 HUNGARY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 282 HUNGARY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 283 HUNGARY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 284 HUNGARY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 285 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 286 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 287 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 288 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 289 AUSTRIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 290 AUSTRIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 291 AUSTRIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 292 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 293 AUSTRIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 294 AUSTRIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 295 AUSTRIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 296 AUSTRIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 297 AUSTRIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 298 AUSTRIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 299 AUSTRIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 300 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 301 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 302 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 303 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 304 LITHUANIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 305 LITHUANIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 306 LITHUANIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 307 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 308 LITHUANIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 309 LITHUANIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 310 LITHUANIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 311 LITHUANIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 312 LITHUANIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 313 LITHUANIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 314 LITHUANIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 315 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 316 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 317 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 318 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 319 NETHERLANDS INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 320 NETHERLANDS SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 321 NETHERLANDS NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 322 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 323 NETHERLANDS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 324 NETHERLANDS MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 325 NETHERLANDS SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 326 NETHERLANDS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 327 NETHERLANDS ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 328 NETHERLANDS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 329 NETHERLANDS BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 330 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 331 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 332 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 333 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 334 SWITZERLAND INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 335 SWITZERLAND SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 336 SWITZERLAND NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 337 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 338 SWITZERLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 339 SWITZERLAND MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 340 SWITZERLAND SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 341 SWITZERLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 342 SWITZERLAND ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 343 SWITZERLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 344 SWITZERLAND BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 345 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 346 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 347 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 348 REST OF EUROPE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 349 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 350 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 351 ASIA-PACIFIC INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 352 ASIA-PACIFIC SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 353 ASIA-PACIFIC NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 354 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 355 ASIA-PACIFIC PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 356 ASIA-PACIFIC MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 357 ASIA-PACIFIC SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 358 ASIA-PACIFIC PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 359 ASIA-PACIFIC ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 360 ASIA-PACIFIC PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 361 ASIA-PACIFIC BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 362 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 363 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 364 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 365 JAPAN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 366 JAPAN INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 367 JAPAN SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 368 JAPAN NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 369 JAPAN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 370 JAPAN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 371 JAPAN MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 372 JAPAN SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 373 JAPAN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 374 JAPAN ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 375 JAPAN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 376 JAPAN BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 377 JAPAN SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 378 JAPAN SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 379 JAPAN SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 380 CHINA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 381 CHINA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 382 CHINA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 383 CHINA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 384 CHINA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 385 CHINA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 386 CHINA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 387 CHINA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 388 CHINA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 389 CHINA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 390 CHINA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 391 CHINA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 392 CHINA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 393 CHINA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 394 CHINA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 395 SOUTH KOREA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 396 SOUTH KOREA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 397 SOUTH KOREA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 398 SOUTH KOREA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 399 SOUTH KOREA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 400 SOUTH KOREA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 401 SOUTH KOREA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 402 SOUTH KOREA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 403 SOUTH KOREA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 404 SOUTH KOREA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 405 SOUTH KOREA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 406 SOUTH KOREA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 407 SOUTH KOREA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 408 SOUTH KOREA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 409 SOUTH KOREA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 410 INDIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 411 INDIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 412 INDIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 413 INDIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 414 INDIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 415 INDIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 416 INDIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 417 INDIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 418 INDIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 419 INDIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 420 INDIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 421 INDIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 422 INDIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 423 INDIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 424 INDIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 425 AUSTRALIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 426 AUSTRALIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 427 AUSTRALIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 428 AUSTRALIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 429 AUSTRALIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 430 AUSTRALIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 431 AUSTRALIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 432 AUSTRALIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 433 AUSTRALIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 434 AUSTRALIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 435 AUSTRALIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 436 AUSTRALIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 437 AUSTRALIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 438 AUSTRALIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 439 AUSTRALIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 440 SINGAPORE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 441 SINGAPORE INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 442 SINGAPORE SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 443 SINGAPORE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 444 SINGAPORE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 445 SINGAPORE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 446 SINGAPORE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 447 SINGAPORE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 448 SINGAPORE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 449 SINGAPORE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 450 SINGAPORE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 451 SINGAPORE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 452 SINGAPORE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 453 SINGAPORE SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 454 SINGAPORE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 455 THAILAND SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 456 THAILAND INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 457 THAILAND SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 458 THAILAND NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 459 THAILAND SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 460 THAILAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 461 THAILAND MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 462 THAILAND SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 463 THAILAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 464 THAILAND ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 465 THAILAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 466 THAILAND BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 467 THAILAND SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 468 THAILAND SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 469 THAILAND SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 470 MALAYSIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 471 MALAYSIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 472 MALAYSIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 473 MALAYSIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 474 MALAYSIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 475 MALAYSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 476 MALAYSIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 477 MALAYSIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 478 MALAYSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 479 MALAYSIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 480 MALAYSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 481 MALAYSIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 482 MALAYSIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 483 MALAYSIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 484 MALAYSIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 485 INDONESIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 486 INDONESIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 487 INDONESIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 488 INDONESIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 489 INDONESIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 490 INDONESIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 491 INDONESIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 492 INDONESIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 493 INDONESIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 494 INDONESIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 495 INDONESIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 496 INDONESIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 497 INDONESIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 498 INDONESIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 499 INDONESIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 500 PHILIPPINES SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 501 PHILIPPINES INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 502 PHILIPPINES SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 503 PHILIPPINES NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 504 PHILIPPINES SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 505 PHILIPPINES PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 506 PHILIPPINES MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 507 PHILIPPINES SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 508 PHILIPPINES PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 509 PHILIPPINES ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 510 PHILIPPINES PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 511 PHILIPPINES BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 512 PHILIPPINES SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 513 PHILIPPINES SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 514 PHILIPPINES SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 515 VIETNAM SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 516 VIETNAM INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 517 VIETNAM SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 518 VIETNAM NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 519 VIETNAM SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 520 VIETNAM PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 521 VIETNAM MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 522 VIETNAM SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 523 VIETNAM PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 524 VIETNAM ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 525 VIETNAM PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 526 VIETNAM BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 527 VIETNAM SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 528 VIETNAM SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 529 VIETNAM SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 530 REST OF ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 531 SOUTH AMERICA SLEEP DISORDER TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 532 SOUTH AMERICA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 533 SOUTH AMERICA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 534 SOUTH AMERICA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 535 SOUTH AMERICA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 536 SOUTH AMERICA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 537 SOUTH AMERICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 538 SOUTH AMERICA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 539 SOUTH AMERICA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 540 SOUTH AMERICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 541 SOUTH AMERICA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 542 SOUTH AMERICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 543 SOUTH AMERICA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 544 SOUTH AMERICA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 545 SOUTH AMERICA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 546 SOUTH AMERICA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 547 BRAZIL SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 548 BRAZIL INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 549 BRAZIL SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 550 BRAZIL NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 551 BRAZIL SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 552 BRAZIL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 553 BRAZIL MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 554 BRAZIL SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 555 BRAZIL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 556 BRAZIL ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 557 BRAZIL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 558 BRAZIL BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 559 BRAZIL SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 560 BRAZIL SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 561 BRAZIL SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 562 ARGENTINA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 563 ARGENTINA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 564 ARGENTINA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 565 ARGENTINA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 566 ARGENTINA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 567 ARGENTINA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 568 ARGENTINA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 569 ARGENTINA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 570 ARGENTINA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 571 ARGENTINA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 572 ARGENTINA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 573 ARGENTINA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 574 ARGENTINA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 575 ARGENTINA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 576 ARGENTINA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 577 PERU SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 578 PERU INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 579 PERU SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 580 PERU NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 581 PERU SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 582 PERU PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 583 PERU MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 584 PERU SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 585 PERU PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 586 PERU ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 587 PERU PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 588 PERU BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 589 PERU SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 590 PERU SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 591 PERU SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 592 REST OF SOUTH AMERICA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 593 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 594 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 595 MIDDLE EAST AND AFRICA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 596 MIDDLE EAST AND AFRICA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 597 MIDDLE EAST AND AFRICA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 598 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 599 MIDDLE EAST AND AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 600 MIDDLE EAST AND AFRICA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 601 MIDDLE EAST AND AFRICA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 602 MIDDLE EAST AND AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 603 MIDDLE EAST AND AFRICA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 604 MIDDLE EAST AND AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 605 MIDDLE EAST AND AFRICA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 606 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 607 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 608 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 609 SOUTH AFRICA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 610 SOUTH AFRICA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 611 SOUTH AFRICA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 612 SOUTH AFRICA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 613 SOUTH AFRICA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 614 SOUTH AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 615 SOUTH AFRICA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 616 SOUTH AFRICA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 617 SOUTH AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 618 SOUTH AFRICA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 619 SOUTH AFRICA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 620 SOUTH AFRICA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 621 SOUTH AFRICA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 622 SOUTH AFRICA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 623 SOUTH AFRICA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 624 SAUDI ARABIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 625 SAUDI ARABIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 626 SAUDI ARABIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 627 SAUDI ARABIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 628 SAUDI ARABIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 629 SAUDI ARABIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 630 SAUDI ARABIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 631 SAUDI ARABIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 632 SAUDI ARABIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 633 SAUDI ARABIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 634 SAUDI ARABIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 635 SAUDI ARABIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 636 SAUDI ARABIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 637 SAUDI ARABIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 638 SAUDI ARABIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 639 UAE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 640 UAE INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 641 UAE SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 642 UAE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 643 UAE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 644 UAE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 645 UAE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 646 UAE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 647 UAE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 648 UAE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 649 UAE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 650 UAE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 651 UAE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 652 UAE SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 653 UAE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 654 EGYPT SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 655 EGYPT INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 656 EGYPT SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 657 EGYPT NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 658 EGYPT SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 659 EGYPT PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 660 EGYPT MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 661 EGYPT SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 662 EGYPT PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 663 EGYPT ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 664 EGYPT PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 665 EGYPT BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 666 EGYPT SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 667 EGYPT SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 668 EGYPT SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 669 KUWAIT SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 670 KUWAIT INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 671 KUWAIT SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 672 KUWAIT NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 673 KUWAIT SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 674 KUWAIT PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 675 KUWAIT MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 676 KUWAIT SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 677 KUWAIT PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 678 KUWAIT ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 679 KUWAIT PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 680 KUWAIT BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 681 KUWAIT SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 682 KUWAIT SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 683 KUWAIT SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 684 ISRAEL SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 685 ISRAEL INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 686 ISRAEL SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)

TABLE 687 ISRAEL NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)

TABLE 688 ISRAEL SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 689 ISRAEL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 690 ISRAEL MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 691 ISRAEL SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)

TABLE 692 ISRAEL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 693 ISRAEL ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)

TABLE 694 ISRAEL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 695 ISRAEL BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)

TABLE 696 ISRAEL SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)

TABLE 697 ISRAEL SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)

TABLE 698 ISRAEL SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)

TABLE 699 REST OF MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET , BY TYPE 2019-2028 (USD MILLION)

 

List of Figure

LIST OF FIGURES 

FIGURE 1 GLOBAL SLEEP DISORDER TREATMENT MARKET: SEGMENTATION

FIGURE 2 GLOBAL SLEEP DISORDER TREATMENT MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL SLEEP DISORDER TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL SLEEP DISORDER TREATMENT MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL SLEEP DISORDER TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL SLEEP DISORDER TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL SLEEP DISORDER TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 8 GLOBAL SLEEP DISORDER TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 GLOBAL SLEEP DISORDER TREATMENT MARKET: MARKET END USER COVERAGE GRID

FIGURE 10 GLOBAL SLEEP DISORDER TREATMENT MARKET: SEGMENTATION

FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL SLEEP DISORDER TREATMENT MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 RISING PREVALENCE OF SLEEPING DISORDERS IS EXPECTED TO DRIVE THE GLOBAL SLEEP DISORDER TREATMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 INSOMNIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL SLEEP DISORDER TREATMENT MARKET IN 2021 & 2028

FIGURE 14 ASIA-PACIFIC IS THE FASTEST GROWING REGION FOR SLEEP DISORDER TREATMENT MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL SLEEP DISORDER TREATMENT MARKET

FIGURE 16 PROPORTION OF AMERICAN TWEENS (8- TO 12- YEAR-OLD) SPENDING TIME WITH SCREEN MEDIA IN A DAY (IN HOURS)

FIGURE 17 PROPORTION OF AMERICAN TEENS (13- TO 18- YEAR-OLD) SPENDING TIME WITH SCREEN MEDIA IN A DAY (IN HOURS)

FIGURE 18 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY TYPE, 2020

FIGURE 19 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY TYPE, 2020-2028 (USD MILLION)

FIGURE 20 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY TYPE, CAGR (2020-2028)

FIGURE 21 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 22 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, 2020

FIGURE 23 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, 2020-2028 (USD MILLION)

FIGURE 24 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, CAGR (2020-2028)

FIGURE 25 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, LIFELINE CURVE

FIGURE 26 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020

FIGURE 27 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020-2028 (USD MILLION)

FIGURE 28 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2028)

FIGURE 29 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 30 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, 2020

FIGURE 31 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, 2020-2028 (USD MILLION)

FIGURE 32 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, CAGR (2020-2028)

FIGURE 33 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, LIFELINE CURVE

FIGURE 34 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, 2020

FIGURE 35 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, 2020-2028 (USD MILLION)

FIGURE 36 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, CAGR (2020-2028)

FIGURE 37 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, LIFELINE CURVE

FIGURE 38 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY END USER, 2020

FIGURE 39 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY END USER, 2020-2028 (USD MILLION)

FIGURE 40 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY END USER, CAGR (2020-2028)

FIGURE 41 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 42 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 43 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)

FIGURE 44 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028)

FIGURE 45 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 46 GLOBAL SLEEP DISORDER TREATMENT MARKET: SNAPSHOT (2020)

FIGURE 47 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020)

FIGURE 48 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 49 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 50 GLOBAL SLEEP DISORDER TREATMENT MARKET: BY TYPE (2020-2028)

FIGURE 51 NORTH AMERICA SLEEP DISORDER TREATMENT MARKET: SNAPSHOT (2020)

FIGURE 52 NORTH AMERICA SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020)

FIGURE 53 NORTH AMERICA SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 54 NORTH AMERICA SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 55 NORTH AMERICA SLEEP DISORDER TREATMENT MARKET: BY TYPE (2020-2028)

FIGURE 56 EUROPE SLEEP DISORDER TREATMENT MARKET: SNAPSHOT (2020)

FIGURE 57 EUROPE SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020)

FIGURE 58 EUROPE SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 59 EUROPE SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 60 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE (2020-2028)

FIGURE 61 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: SNAPSHOT (2020)

FIGURE 62 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020)

FIGURE 63 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 64 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 65 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY TYPE (2020-2028)

FIGURE 66 SOUTH AMERICA SLEEP DISORDER TREATMENT MARKET: SNAPSHOT (2020)

FIGURE 67 SOUTH AMERICA SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020)

FIGURE 68 SOUTH AMERICA SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 69 SOUTH AMERICA SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 70 SOUTH AMERICA SLEEP DISORDER TREATMENT MARKET: BY TYPE (2020-2028)

FIGURE 71 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: SNAPSHOT (2020)

FIGURE 72 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020)

FIGURE 73 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 74 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 75 MIDDLE EAST AND AFRICA SLEEP DISORDER TREATMENT MARKET: BY TYPE (2020-2028)

FIGURE 76 GLOBAL SLEEP DISORDER TREATMENT MARKET: COMPANY SHARE 2020 (%)

FIGURE 77 NORTH AMERICA SLEEP DISORDER TREATMENT MARKET: COMPANY SHARE 2020 (%)

FIGURE 78 EUROPE SLEEP DISORDER TREATMENT MARKET: COMPANY SHARE 2020 (%)

FIGURE 79 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: COMPANY SHARE 2020 (%)

 

View Detailed Information Right Arrow

منهجية البحث

يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.

منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.

التخصيص متاح

تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.

Frequently Asked Questions

The market is segmented based on ,  By Type (Insomnia, Sleep Apnea, Restless Legs Syndrome (RLS), Narcolepsy and Others), Treatment (Pharmacological Therapy, Mechanical Therapy, Mandibular Advancement Devices, Hypoglossal Nerve Stimulator, Surgery and Others) Route of Administration (Oral, Parenteral and Others), Drugs Type (Branded and Generics), Population Type (Children and Adults), End User (Hospitals, Specialty Clinics, Home Healthcare, Ambulatory Surgical Center and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others) – Industry Trends and Forecast to 2029 .
The Global Sleep Disorder Treatment Market size was valued at USD 8551.42 USD Million in 2021.
The Global Sleep Disorder Treatment Market is projected to grow at a CAGR of 8.9% during the forecast period of 2022 to 2029.
The major players operating in the market include Jazz Pharmaceuticals, Pfizer, Viatris, Arbor Pharmaceuticals, Aurobindo Pharma, Sanofi, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Lupin Pharmaceuticals, Taj Pharmaceuticals, Eli Lilly and Company, Mallkrodt, Alembic Pharmaceuticals, Apotex, Dr. Reddy's Laboratories, Teva Pharmaceuticals Industries, Taro Pharmaceutical Industries, DeVilbiss Healthcare, ResMed.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.